These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10030073)

  • 21. Persistent infections of a field strain of rabies virus in murine neuroblastoma (NA-C1300) cell cultures.
    Webster WA; Charlton KM; Casey GA
    Can J Vet Res; 1989 Oct; 53(4):445-8. PubMed ID: 2590871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
    Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW
    Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dissemination of rabies virus into cranial nerves and other tissues of experimentally infected goats and dogs and naturally infected skunks.
    Umoh JU; Blenden DC
    Int J Zoonoses; 1982 Jun; 9(1):1-11. PubMed ID: 6757169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell attachment to microcarriers affects growth, metabolic activity, and culture productivity in bioreactor culture.
    Nam JH; Ermonval M; Sharfstein ST
    Biotechnol Prog; 2007; 23(3):652-60. PubMed ID: 17500530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental study of rabies virus (Vnukovo-32 strain) persistence in white mice].
    Kravchenko AT; Babenko GS; Romanova LN; Davydova AV
    Vopr Virusol; 1976; (5):569-74. PubMed ID: 1007228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.
    Wu SC; Liu CC; Lian WC
    Vaccine; 2004 Sep; 22(29-30):3858-64. PubMed ID: 15364432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The preparation of cultured rabies virus and the production of antiserum for human use.
    Consales CA; Valentini JG; Albas A; Mendonca RM; Fuches RM; Soares MA; Pereira CA
    J Biol Stand; 1988 Jan; 16(1):27-32. PubMed ID: 3350822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo studies of pathogenic, immunogenic and protective properties of Roma strain rabies virus recovered from a persistently infected BHK21 cell line.
    Grassi M; Wandeler AI; Gerber H; Peterhans E
    Microbiologica; 1987 Apr; 10(2):217-27. PubMed ID: 3587068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte proliferative response to rabies virus antigen.
    Melino G; Concato C; Menichella D; Vescia N; Mastroeni I; Pestalozza S; Buonavoglia C; Caliò R
    Microbiologica; 1989 Jul; 12(3):215-23. PubMed ID: 2779457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic cell culture infection with the rabies virus].
    Bogomolova NN; Boriskin IuS; Bektemirova MS; Osidze DF
    Vopr Virusol; 1977; (5):561-5. PubMed ID: 337676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Batch, fed-batch, and microcarrier cultures with CHO cell lines in a pressure-cycle driven miniaturized bioreactor.
    Kim BJ; Zhao T; Young L; Zhou P; Shuler ML
    Biotechnol Bioeng; 2012 Jan; 109(1):137-45. PubMed ID: 21965160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
    Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
    Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation and multiplication of rabies virus in cell lines under conditions of routine rabies diagnosis].
    Seroka D; Koncki A; Labuńska E
    Med Dosw Mikrobiol; 1994; 46(3):215-23. PubMed ID: 7996940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H; Rourou S; Majoul S; Loukil H
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of human mesenchymal stem cells on microcarriers.
    Hewitt CJ; Lee K; Nienow AW; Thomas RJ; Smith M; Thomas CR
    Biotechnol Lett; 2011 Nov; 33(11):2325-35. PubMed ID: 21769648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient suspension bioreactor expansion of murine embryonic stem cells on microcarriers in serum-free medium.
    Alfred R; Radford J; Fan J; Boon K; Krawetz R; Rancourt D; Kallos MS
    Biotechnol Prog; 2011; 27(3):811-23. PubMed ID: 21538971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein.
    Bunschoten H; Klapmuts RJ; Claassen IJ; Reyneveld SD; Osterhaus AD; Uytdehaag FG
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1513-21. PubMed ID: 2471814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the ERA antirabies vaccine against antigenic variants of rabies virus in various post-immunization periods].
    Cordeiro CC; Silva EV; Miguel O; Germano PM
    Rev Saude Publica; 1990 Dec; 24(6):512-7. PubMed ID: 2103072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hollow microcarriers for large-scale expansion of anchorage-dependent cells in a stirred bioreactor.
    YekrangSafakar A; Acun A; Choi JW; Song E; Zorlutuna P; Park K
    Biotechnol Bioeng; 2018 Jul; 115(7):1717-1728. PubMed ID: 29578573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.